International Stem Cell Co. (OTCMKTS:ISCO) Sees Significant Increase in Short Interest

International Stem Cell Co. (OTCMKTS:ISCO) was the recipient of a significant increase in short interest during the month of May. As of May 28th, there was short interest totalling 5,600 shares, an increase of 5,500.0% from the May 13th total of 100 shares. Based on an average daily volume of 20,900 shares, the short-interest ratio is presently 0.3 days.

International Stem Cell stock traded down $0.02 during midday trading on Friday, hitting $0.37. 15,850 shares of the stock were exchanged, compared to its average volume of 11,269. The stock’s 50-day moving average price is $0.52. International Stem Cell has a fifty-two week low of $0.30 and a fifty-two week high of $1.08.

About International Stem Cell

International Stem Cell Corporation focuses on the development of therapeutic and biomedical products worldwide. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; liver cells to treat various congenital and acquired liver diseases; and islet cells for the treatment of diabetes.

Read More: Why do companies pay special dividends?

Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.